MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-11-0026064
Aricon Pharma Private Limited
Aricon Pharma Private Limited - trading in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹27.43 Lakh
▲ 129% YoY
Net profit · FY 2024
₹7,940
Net margin 0.3%
EBITDA · FY 2024
₹23,970
EBITDA margin 0.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Aricon Pharma Private Limited
Data last updated:
Aricon Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 10 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2016PTC292352. Its GSTIN is 10AAOCA3629G1ZY (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Shweta Singh and Rajesh Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 106 Plot No. H – 1/49 Block H – 1 S/F/F/Side Raja Puri Gali No. – 25, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2024, the company reported a revenue of ₹27.43 Lakh, a growth of 129% compared to the previous year. For the same year it recorded a net profit of ₹7,940 (net margin 0.3%) and EBITDA of ₹23,970 (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 1% over five years.
Aricon Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0026064). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Aricon Pharma Private Limited
CIN U24100DL2016PTC292352
Registration Number 292352
Incorporation Date 10 March 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0026064
Recognitions & Rankings of Aricon Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No. 106 Plot No. H – 1/49 Block H – 1 S/F/F/Side Raja Puri Gali No. – 25, New Delhi, Delhi, India – 110059
- IndustryTrading, Other Wholesale, Wholesale
Comprehensive company report
Aricon Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Aricon Pharma Private Limited
The main business activity of Aricon Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aricon Pharma Private Limited FY 2025 filings available
Aricon Pharma Private Limited reported revenue of ₹27.43 Lakh (up 129% YoY) for FY 2024.
Revenue · FY 2024
₹27.43 Lakh ▲ 129%
Net profit · FY 2024
₹7,940 margin 0.3%
EBITDA · FY 2024
₹23,970 margin 0.9%
Compounded Annual Growth Rate (CAGR) of Aricon Pharma Private Limited
Revenue CAGR growth
1 year
▲ 129%
3 years · compounded
▲ 8%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▲ 144%
3 years · compounded
▼ 52%
5 years · compounded
▼ 14%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 129% growth in the latest year. EBITDA rose 144% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aricon Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹23,970 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7,940 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aricon Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aricon Pharma are in the company report.
Premium access
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Aricon Pharma Private Limited
Aricon Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shweta Singh Also directs: Deveon Biotech LLP | Director | 19 Mar 2021 | 5 Years 7 Months | Current |
| Rajesh Kumar Singh | Director | 10 Mar 2016 | 10 Years 7 Months | Current |
| Kumar Saurabh Also directs: Eesse Life Science LLP | Director | 10 Mar 2016 | 10 Years 7 Months | Current |
Peer Comparison of Aricon Pharma Private Limited
Aricon Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sap Integrated Security & IT Services Private Limited | ₹27.45 Lakh (FY 2025) | •••• | •••• | -23.0% | •••• | New Delhi, Delhi, India |
| Namokar Timber India Private Limited | ₹27.44 Lakh (FY 2021) | •••• | •••• | -59.0% | •••• | Delhi, India |
| Scarlet India Private Limited | ₹27.44 Lakh (FY 2022) | •••• | •••• | -27.0% | •••• | Delhi, India |
| Shamadou & Brothers Trading Private Limited | ₹27.44 Lakh (FY 2022) | •••• | •••• | -34.0% | •••• | Mumbai, Maharashtra, India |
| J & Y Fabrics Private Limited | ₹27.44 Lakh (FY 2024) | •••• | •••• | 47.0% | •••• | Mumbai, Maharashtra, India |
| Aricon Pharma Private Limited this company | ₹27.43 Lakh (FY 2024) | •••• | •••• | 129.0% | •••• | New Delhi, Delhi, India |
| Seafi Export India Private Limited | ₹27.43 Lakh (FY 2025) | •••• | •••• | -66.0% | •••• | Kolkata, West Bengal, India |
| Paramount Infracon Business Private Limited | ₹27.43 Lakh (FY 2024) | •••• | •••• | -29.0% | •••• | Delhi, India |
| Trulive Medics Private Limited | ₹27.43 Lakh (FY 2024) | •••• | •••• | -25.0% | •••• | Bharuch, Gujarat, India |
| Suthar Motors Private Limited | ₹27.43 Lakh (FY 2024) | •••• | •••• | 11.0% | •••• | Sumerpur, Rajasthan, India |
| Anokhiraj Properties Private Limited | ₹27.43 Lakh (FY 2024) | •••• | •••• | 71.0% | •••• | Siliguri, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Aricon Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Aricon Pharma Private Limited
Aricon Pharma Private Limited is audited by MANMOHAN SINGH & CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MANMOHAN SINGH & CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Aricon Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aricon Pharma Private Limited
Aricon Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Aricon Pharma Private Limited
Employment history and EPFO contributions of people linked to Aricon Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aricon Pharma Private Limited
Aricon Pharma Private Limited has 5 board changes on record since 2016: 3 appointments and 2 cessations. The latest: Rajneesh Kumar Singh ceased to be Director on 19 Mar 2021.
AGM
Aricon Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aricon Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Rajneesh Kumar Singh ceased to be Director.
Appointed
Shweta Singh was appointed as Director.
Ceased
Raman Kumar ceased to be Director.
Appointed
Kumar Saurabh was appointed as Director.
Appointed
Rajesh Kumar Singh was appointed as Director.
Incorporation
10 Mar 2016
Aricon Pharma Private Limited was registered on 10 Mar 2016 with Roc Delhi & aged 10 years 7 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Aricon Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aricon Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aricon Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aricon Pharma Private Limited
Aricon Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAOCA3629G1ZY | Bihar | Active | 16 Mar 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aricon Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aricon Pharma Private Limited
Aricon Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 10 March 2016 (10+ years old) and is registered under CIN U24100DL2016PTC292352.
Aricon Pharma reported revenue of ₹27.43 Lakh for FY 2024 (up 129% YoY).
Aricon Pharma has 3 current directors:
- Shweta Singh - Director
- Rajesh Kumar Singh - Director
- Kumar Saurabh - Director
Aricon Pharma reported a net profit of ₹7,940 (net margin 0.3%) and EBITDA of ₹23,970 (EBITDA margin 0.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aricon Pharma is 8% over three years and 1% over five years. In the latest year (FY 2024) revenue rose 129%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aricon Pharma is 10AAOCA3629G1ZY, registered in Bihar.
The CIN (Corporate Identification Number) of Aricon Pharma is U24100DL2016PTC292352. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aricon Pharma was incorporated on 10 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Aricon Pharma by revenue are Sap Integrated Security & IT Services Private Limited, Namokar Timber India Private Limited, Scarlet India Private Limited, Shamadou & Brothers Trading Private Limited, J & Y Fabrics Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Rajneesh Kumar Singh ceased to be Director on 19 Mar 2021. Shweta Singh was appointed as Director on 19 Mar 2021. Raman Kumar ceased to be Director on 31 Jan 2019. Aricon Pharma has 5 board changes on record in total.
Yes, Aricon Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0026064).